TCTR20220322006已完成不适用
Perampanel as adjunctive therapy in drug resistant epilepsy in adolescents and children waiting for epilepsy surgery: a multicenter observational study in Thailand
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1 Months 至 18 Years（—）
- 性别
- All
入选标准
- •1. patients with the age between 1 month and 18 years treated with PER, 2. having complete records of baseline seizure frequency for at least 3 months prior to starting PER, 3. taking PER for at least 6 months, 4. diagnosed with DRE and in the waiting list for epilepsy surgery.
排除标准
- •1. patients with generalized epilepsy, 2. patients with epilepsy syndrome.
研究者
相似试验
招募中
Unknown
PROPELLER studyStrokeJPRN-jRCTs051230107Yamada Shuichi54
招募中
1 期
Adjunct treatment of multidrug resistant (MDR) or extreme drug resistant (XDR) Tuberculosis (TB) with autologous mesenchymal stem cells.multi-drug resistant (MDR) tuberculosis extreme drug resistant (XDR)tuberculosisA15-A19U82.1Resistance to methicillinTuberculosisDRKS00000763Republican Research and Practical Center for Pulmonology and Tuberculosis (RRPCPT), Minsk Belarus40
进行中（未招募）
4 期
PrEgabalin for Treatment Resistant generalised Anxiety disorder (PETRA)Generalised Anxiety Disorder (GAD)Mental and Behavioural DisordersISRCTN16993990niversity College London498
已完成
不适用
Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon)Refractory EpilepsyNCT02876289Hospices Civils de Lyon110
进行中（未招募）
不适用
Study on the treatment of therapy-resistant enuresis with desmopressin and reboxetine; a randomised, placebo-controlled, double-blinded, cross-over studyEUCTR2008-002636-15-SEppsala University Children´s Hospital